Charles Schwab Investment Management Inc Syndax Pharmaceuticals Inc Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 704,823 shares of SNDX stock, worth $10.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
704,823
Previous 695,947
1.28%
Holding current value
$10.2 Million
Previous $13.4 Million
30.45%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding SNDX
# of Institutions
233Shares Held
96.9MCall Options Held
1.39MPut Options Held
543K-
Kynam Capital Management, LP Princeton, NJ8.52MShares$123 Million7.14% of portfolio
-
Black Rock Inc. New York, NY7.91MShares$114 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY5.95MShares$86.2 Million0.01% of portfolio
-
Morgan Stanley New York, NY5.31MShares$76.9 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.88MShares$70.7 Million0.0% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $819M
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...